Yahoo Finance • 6 months ago
Enovis Corporation Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following inve... Full story
Yahoo Finance • 11 months ago
Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive M&A Integration Expertise and Commercial and Operating Experience Across Key... Full story
Yahoo Finance • 12 months ago
Wilmington, DE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wedne... Full story
Yahoo Finance • 12 months ago
Continued strong momentum with third quarter sales growth of 9% and strong adjusted EBITDA margin expansion Organic growth of 10% in Recon and 4% in P&R Reported a third quarter net loss from continuing operations of $0.36 per share with a... Full story
Yahoo Finance • last year
Wilmington, DE, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase the latest technologies from its Surgical business, including an upd... Full story
Yahoo Finance • last year
Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced the pricing of $400 million aggregate principal amount of 3.875% Convertible Senior Notes due 2028 (the “Notes”... Full story
Yahoo Finance • last year
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today released the following preliminary information about its performance for the third quarter ended September 29, 2023. Rev... Full story
Yahoo Finance • last year
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced its intention to offer, subject to market conditions and other factors, $400 million aggregate principal amount... Full story
Yahoo Finance • last year
Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference call and live webcast to discuss its th... Full story
Yahoo Finance • last year
Creating a high-growth, globalreconstructionleader with ~$1 billion in annual revenueAttractive margin profile and meaningful synergies expected to increaseprofitability Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corpora... Full story
Yahoo Finance • last year
Wilmington, DE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Today, Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, announced it will showcase new products from its recent acquisitions of Novastep® and the exte... Full story
Yahoo Finance • last year
Wilmington, DE, July 11, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference call and live webcast to discuss its s... Full story
Yahoo Finance • last year
Wilmington, DE, July 06, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced today that it has been recognized as one of America’s Greatest Workplaces 2023 by New... Full story
Yahoo Finance • last year
Wilmington, DE, June 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it closed the acquisition of Novastep®, a subsidiary of Amplitude Surgical... Full story
Yahoo Finance • 2 years ago
Strong start to the year with sales growth of 8%, organic growth of 9% and strong EBITDA margin expansion Organic growth of 9% reflects 19% organic growth in Recon and 4% organic growth in P&R Reported a first quarter net loss from continu... Full story
Yahoo Finance • 2 years ago
Wilmington, DE, April 13, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first q... Full story
Yahoo Finance • 2 years ago
Wilmington, DE, April 03, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire Novastep®, a subsidiary of Amplitude Surgical... Full story
Yahoo Finance • 2 years ago
Wilmington, DE, March 03, 2023 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that it will feature its next generation of medical technology at the upcoming American Acade... Full story
Yahoo Finance • 2 years ago
Wilmington, DE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that it has been recognized as one of America’s Greatest Workplaces for Diversity by Ne... Full story
Yahoo Finance • 2 years ago
Wilmington, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2022... Full story